ES2042437T1 - Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila. - Google Patents
Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila.Info
- Publication number
- ES2042437T1 ES2042437T1 ES91913037T ES91913037T ES2042437T1 ES 2042437 T1 ES2042437 T1 ES 2042437T1 ES 91913037 T ES91913037 T ES 91913037T ES 91913037 T ES91913037 T ES 91913037T ES 2042437 T1 ES2042437 T1 ES 2042437T1
- Authority
- ES
- Spain
- Prior art keywords
- lipoprotein
- incorporation
- pct
- substance
- lipophyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004895 Lipoproteins Human genes 0.000 title abstract 6
- 108090001030 Lipoproteins Proteins 0.000 title abstract 6
- 238000010348 incorporation Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000000126 substance Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 3
- 239000000839 emulsion Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 108010053156 lipid transfer protein Proteins 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000012071 phase Substances 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
METODO DE PREPARACION DE UNA LIPOPROTEINA MODIFICADA POR INCORPORACION DE AL MENOS UNA SUSTANCIA ACTIVA LIPOFILA DISTINTA DE UN TRIGLICERIDO, CARACTERIZADO EN QUE SE INCORPORA DICHA SUSTANCIA ACTIVA A UNA EMULSION DE UNA FASE LIPIDICA EN UNA FASE CONTINUA ACUOSA, EN QUE SE AÑADE A LA EMULSION, AGITANDO, UNA LIPOPROTEINA INICIAL Y AL MENOS UNA PROTEINA DE TRANSFERENCIA DE LIPIDOS, EN QUE SE AISLA SEGUN LOS METODOS CONOCIDOS LA LIPOPROTEINA EN LA QUE LA SUSTANCIA ACTIVA ESTA INCORPORADA; LIPOPROTEINA MODIFICADA ASI OBTENIDA, Y COMPOSICION FARMACEUTICA O COSMETICA QUE CONTIENE TAL LIPOPROTEINA MODIFICADA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9008980A FR2664500B1 (fr) | 1990-07-13 | 1990-07-13 | Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2042437T1 true ES2042437T1 (es) | 1993-12-16 |
Family
ID=9398707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91913037T Pending ES2042437T1 (es) | 1990-07-13 | 1991-07-12 | Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5324821A (es) |
EP (1) | EP0491921B1 (es) |
JP (1) | JPH0786089B2 (es) |
AT (1) | ATE133867T1 (es) |
AU (1) | AU654144B2 (es) |
CA (1) | CA2066416A1 (es) |
DE (1) | DE69117029T2 (es) |
ES (1) | ES2042437T1 (es) |
FR (1) | FR2664500B1 (es) |
GR (1) | GR920300128T1 (es) |
WO (1) | WO1992000761A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869534A (en) * | 1992-05-21 | 1999-02-09 | The Picower Institute For Medical Research | Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
US5615801A (en) * | 1990-06-06 | 1997-04-01 | The Coca-Cola Company | Juice concentrate package for postmix dispenser |
US5842603A (en) * | 1990-06-06 | 1998-12-01 | The Coca-Cola Company | Postmix juice dispenser |
US5874059A (en) * | 1992-04-02 | 1999-02-23 | Fundacao E.J. Zerbini | Microemulsions labelled with radioactivity used as means for targeting neoplastic cells |
US6610321B2 (en) | 1996-07-03 | 2003-08-26 | University Of Pittsburgh | Emulsion formulations for hydrophilic active agents |
GB2321455A (en) * | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
US6514523B1 (en) | 2000-02-14 | 2003-02-04 | Ottawa Heart Institute Research Corporation | Carrier particles for drug delivery and process for preparation |
US7803400B2 (en) | 2002-12-03 | 2010-09-28 | Blanchette Rockefeller Neurosciences Institute | Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
EP1581186A2 (en) * | 2002-12-03 | 2005-10-05 | Blanchette Rockefeller Neurosciences Institute | Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
JP4777873B2 (ja) | 2003-02-14 | 2011-09-21 | チルドレンズ ホスピタル アンド リサーチ センター アット オークランド | 親油性薬物送達ビヒクルおよびこれらの使用方法 |
DE10324256B4 (de) * | 2003-05-28 | 2010-04-22 | Merz Pharma Gmbh & Co. Kgaa | Lipid-Tranferprotein-Systeme und deren kosmetische/dermatologische Anwendung |
WO2006073419A2 (en) * | 2004-04-01 | 2006-07-13 | Gang Zheng | Lipoprotein nanoplatforms |
CN102159247A (zh) * | 2008-07-30 | 2011-08-17 | 日东电工株式会社 | 药物载体 |
US20160346219A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
MX2018001227A (es) | 2015-07-30 | 2018-03-26 | Macrogenics Inc | Moleculas de union a pd-1 y metodos de uso de las mismas. |
UA125611C2 (uk) | 2015-12-14 | 2022-05-04 | Макродженікс, Інк. | Біспецифічні молекули, що мають імунореактивність відносно pd-1 і ctla-4, і способи їх застосування |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59163824A (ja) * | 1983-03-08 | 1984-09-14 | Hitachi Ltd | アライメントスコ−プ |
SE456136B (sv) * | 1985-06-17 | 1988-09-12 | Oncholab Ab | Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein) |
US5023271A (en) * | 1985-08-13 | 1991-06-11 | California Biotechnology Inc. | Pharmaceutical microemulsions |
FR2609399A1 (fr) * | 1987-01-13 | 1988-07-15 | Ire Celltarg Sa | Procede d'incorporation d'un ou plusieurs principes actifs lipophiles dans des lipoproteines, lipoproteines obtenues et composition pharmaceutique les contenant |
US5084441A (en) * | 1987-03-04 | 1992-01-28 | Shaw Jack M | Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance |
WO1988009345A1 (en) * | 1987-05-20 | 1988-12-01 | The Rogosin Institute | Reconstituted hdl particles and uses thereof |
DE3815473A1 (de) * | 1988-05-06 | 1989-11-16 | Karl Heinz Prof Dr Dr Schmidt | Wirkstoff-system fuer den lipidaustausch mit zielstrukturen |
US5169933A (en) * | 1988-08-15 | 1992-12-08 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
-
1990
- 1990-07-13 FR FR9008980A patent/FR2664500B1/fr not_active Expired - Fee Related
-
1991
- 1991-07-12 CA CA002066416A patent/CA2066416A1/fr not_active Abandoned
- 1991-07-12 AU AU82157/91A patent/AU654144B2/en not_active Ceased
- 1991-07-12 DE DE69117029T patent/DE69117029T2/de not_active Expired - Fee Related
- 1991-07-12 JP JP3512790A patent/JPH0786089B2/ja not_active Expired - Fee Related
- 1991-07-12 WO PCT/FR1991/000573 patent/WO1992000761A1/fr active IP Right Grant
- 1991-07-12 AT AT91913037T patent/ATE133867T1/de not_active IP Right Cessation
- 1991-07-12 EP EP91913037A patent/EP0491921B1/fr not_active Expired - Lifetime
- 1991-07-12 US US07/838,444 patent/US5324821A/en not_active Expired - Fee Related
- 1991-07-12 ES ES91913037T patent/ES2042437T1/es active Pending
-
1993
- 1993-03-16 GR GR920300128T patent/GR920300128T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU654144B2 (en) | 1994-10-27 |
DE69117029D1 (de) | 1996-03-21 |
EP0491921A1 (fr) | 1992-07-01 |
GR920300128T1 (en) | 1993-03-16 |
DE69117029T2 (de) | 1996-09-19 |
CA2066416A1 (fr) | 1992-01-14 |
WO1992000761A1 (fr) | 1992-01-23 |
FR2664500A1 (fr) | 1992-01-17 |
JPH06500768A (ja) | 1994-01-27 |
US5324821A (en) | 1994-06-28 |
JPH0786089B2 (ja) | 1995-09-20 |
EP0491921B1 (fr) | 1996-02-07 |
ATE133867T1 (de) | 1996-02-15 |
AU8215791A (en) | 1992-02-04 |
FR2664500B1 (fr) | 1994-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2042437T1 (es) | Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila. | |
FI95538B (fi) | Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi | |
AU567271B2 (en) | Lyophilization of oil in water emulsion to give galenic form for oral administration | |
AU643690B2 (en) | Injectable multi-phase emulsions | |
PT97101A (pt) | Processo para a preparacao de lipossomas heterovesiculares | |
DE69616523D1 (de) | Verfahren zur baladung von lipidvesikeln | |
DK0814835T3 (da) | Fremgangsmåde til forøgelse af immunogenitet, opnået produkt og farmaceutisk præparat | |
DK653688D0 (da) | Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater | |
SE9402106D0 (sv) | Lipidbaserad komposition | |
FI963066A (fi) | Lipofiiliset kantoainevalmisteet | |
ES2052755T3 (es) | Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas. | |
MY121201A (en) | Pharmaceutical emulsion. | |
ES2089497T3 (es) | Derivados de 23-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos. | |
ES2170813T3 (es) | Acidos 2,2-dicloroalcanocarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar la resistencia a la insulina. | |
MX9204637A (es) | Nuevos derivados de pirazina y procedimiento para su preparacion. | |
KR870006901A (ko) | 인터로이킨-2 조성물의 제조방법 | |
ES2161364T3 (es) | Pseudoemulsiones estabilizadas y su procedimiento de preparacion. | |
PT84657B (pt) | Processo para a fluidificacao, mediante glicofurol, de composicoes farmaceuticas contendo fosfatidil-colina, destinadas a serem introduzidas em capsulas moles de gelatina | |
DK0629128T3 (da) | Vandig phospholipidvesikeldispersion, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
EP0652755A1 (en) | THERAPEUTIC USE OF PHOSPHORYL-L-SERINE-N-ACYL-SPHINGOSINE. | |
DK0689441T3 (da) | Farmaceutisk præparat i form af et kit omfattende prostaglandin E1 | |
PT94685A (pt) | Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem | |
RU1216844C (ru) | Способ стимул ции охоты у крупного рогатого скота | |
ES2036219T3 (es) | 2,2; 6,6-dietilen-3-oxo-17alfa-pren-4-en-21,17alfa-carbolactonas, procedimiento para su preparacion y preparados farmaceuticos que las contienen. | |
KR930012025A (ko) | 한방성 b형 간염치료제 |